Precision-Panc in the Press

A recent publication in Gatroenterolgy has led to some great press for the Precision-Panc platform.

The team used cells grown in the lab and organoids to identify molecular markers that can predict which tumours will respond to a number of drugs that target damaged DNA.

This strategy is now being taken forward into the PRIMUS 004 trial – more information about this will be added to the website very soon so keep an eye out.

If you would like to know more about the recent publication please have a look at the links below.

https://www.scotsman.com/health/glasgow-university-researchers-develop-breakthrough-new-approach-treating-pancreatic-cancer-3000473

https://medicalxpress.com/news/2020-10-scientists-precision-medicine-approach-dna.html

https://www.myscience.org/news/2020/scientists_develop_new_precision_medicine_approach_to_treating_damaged_dna_in_pancreatic_cancer-2020-glasgow

http://www.pharmafile.com/news/561373/university-glasgow-research-details-promising-precision-medicine-approach-pancreatic-can

https://infosurhoy.com/news-summary/scientists-develop-new-precision-medicine-approach-to-treating-damaged-dna-in-pancreatic-cancer/

https://www.ethicaleditor.com/health/scientists-develop-new-precision-medicine-approach-to-treating-damaged-dna-in-pancreatic-cancer/

https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2020-10-12-scientists-develop-new-precision-medicine-approach-for-pancreatic-cancer